| Ytd | -88.23% | |
| 1y | -82.64% |
| Open | 0.42 | Prev Close | 0.42 | Low | 0.42 | High | 0.42 | Mkt Cap | 21.73M |
| Vol | 2.84K | Avg Vol | 827.42K | EPS | -0.38 | P/E | -1.11 | Forward P/E | -3.81 |
| Beta | 1.43 | Short Ratio | 0.22 | Inst. Own | 48.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.69 | 200-d Avg | 2.72 | 1yr Est | 6.04 |
MDXH News
Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focus
The publication represents the first major peer-reviewed milestone from the Oxford collaboration and
Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the pri
TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price ta
US stocks up, Dow gains 250+ pts. Tech sector up 0.8%, healthcare down 0.3%. Retail sales rise 0.5%
Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target
BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price targe
Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. S
MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.0
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst cons
On Tuesday, 647 companies set new 52-week lows.